Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Thurmond

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Lancet (London, England)|April 12, 2002
Genetic variations in HLA-B region and hypersensitivity reactions to abacavirSeth Hetherington, Arlene R Hughes, Michael Mosteller, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumorsPravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Lancet (London, England)|April 12, 2002
Genetic variations in HLA-B region and hypersensitivity reactions to abacavirSeth Hetherington, Arlene R Hughes, Michael Mosteller, et al.
Molecular Psychiatry|December 9, 2015
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsM Fava, K Johe, L Ereshefsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumorsPravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Pageof 7